Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5133)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,131
Price
$565.44
Total Value
$1.20M
Shares Held After
26,123
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
422
Price
$564.30
Total Value
$238.14K
Shares Held After
28,254
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$562.91
Total Value
$112.58K
Shares Held After
28,676
% of Holdings
0.7%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
3,195
Price
$65.95
Total Value
$210.71K
Shares Held After
359,194
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
10,456
Price
$64.82
Total Value
$677.71K
Shares Held After
362,389
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$569.99
Total Value
$159.60K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$569.42
Total Value
$613.26K
Shares Held After
40,793
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,437
Price
$568.33
Total Value
$816.69K
Shares Held After
41,870
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,280
Price
$567.45
Total Value
$1.29M
Shares Held After
43,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,117
Price
$566.33
Total Value
$1.20M
Shares Held After
45,587
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,811
Price
$565.34
Total Value
$1.02M
Shares Held After
47,704
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$564.11
Total Value
$205.90K
Shares Held After
49,515
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$563.01
Total Value
$74.88K
Shares Held After
49,880
% of Holdings
0.3%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
12,728
Price
$5.12
Total Value
$65.17K
Shares Held After
688,893
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,108
Price
$26.76
Total Value
$29.65K
Shares Held After
227,367
% of Holdings
0.5%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — Chief Operating Officer, EVP
Shares
59
Price
$7.53
Total Value
$444.27
Shares Held After
8,562
% of Holdings
0.7%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
77
Price
$7.53
Total Value
$579.81
Shares Held After
7,838
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$7.53
Total Value
$1.95K
Shares Held After
12,040
% of Holdings
2.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
79
Price
$7.53
Total Value
$594.87
Shares Held After
7,954
% of Holdings
1.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,032
Price
$26.76
Total Value
$27.62K
Shares Held After
143,934
% of Holdings
0.7%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,129
Price
$26.76
Total Value
$30.21K
Shares Held After
467,665
% of Holdings
0.2%
HARROW, INC. (HROW)
Graves Adrienne L — Director
Shares
1,000
Price
$31.07
Total Value
$31.07K
Shares Held After
1,000
% of Holdings
100.0%
HARROW, INC. (HROW)
SILVERNAIL LAUREN P — Director
Shares
1,000
Price
$31.00
Total Value
$31.00K
Shares Held After
1,000
% of Holdings
100.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
198
Price
$28.15
Total Value
$5.57K
Shares Held After
1,394,094
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
118,037
Price
$27.19
Total Value
$3.21M
Shares Held After
1,394,292
% of Holdings
7.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
60,000
Price
$16.88
Total Value
$1.01M
Shares Held After
96,928
% of Holdings
61.9%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
43,401
Price
$0.91
Total Value
$39.49K
Shares Held After
628,863
% of Holdings
6.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,700
Price
$0.92
Total Value
$5.24K
Shares Held After
291,566
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
SULIMAN SHEHNAAZ — Director
Shares
5,740
Price
$25.12
Total Value
$144.19K
Shares Held After
27,951
% of Holdings
17.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
700
Price
$61.16
Total Value
$42.81K
Shares Held After
16,406
% of Holdings
4.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
800
Price
$60.34
Total Value
$48.27K
Shares Held After
17,106
% of Holdings
4.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,600
Price
$59.19
Total Value
$272.26K
Shares Held After
17,906
% of Holdings
20.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,190
Price
$58.34
Total Value
$244.47K
Shares Held After
22,506
% of Holdings
15.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Soergel David — Chief Medical Officer
Shares
844
Price
$515.90
Total Value
$435.42K
Shares Held After
11,075
% of Holdings
7.1%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
620
Price
$81.14
Total Value
$50.31K
Shares Held After
40,411
% of Holdings
1.5%
Outset Medical, Inc. (OM)
Brottem John L. — General Counsel
Shares
2,638
Price
$3.70
Total Value
$9.76K
Shares Held After
30,277
% of Holdings
8.0%
Outset Medical, Inc. (OM)
Trigg Leslie — Director
Shares
3,445
Price
$3.70
Total Value
$12.75K
Shares Held After
98,874
% of Holdings
3.4%
Outset Medical, Inc. (OM)
Nash Marc — EVP Operations R&D & Service
Shares
1,582
Price
$3.70
Total Value
$5.85K
Shares Held After
38,393
% of Holdings
4.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
3,000
Price
$18.76
Total Value
$56.28K
Shares Held After
3,622
% of Holdings
45.3%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.58
Total Value
$10.58K
Shares Held After
9,450
% of Holdings
10.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
4,643
Price
$92.21
Total Value
$428.13K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.74
Total Value
$1.04M
Shares Held After
1,122,626
% of Holdings
4.3%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
200
Price
$69.12
Total Value
$13.82K
Shares Held After
11,589
% of Holdings
1.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,512
Price
$68.23
Total Value
$103.16K
Shares Held After
11,789
% of Holdings
11.4%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
2,088
Price
$67.53
Total Value
$141.00K
Shares Held After
13,301
% of Holdings
13.6%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
6,200
Price
$66.69
Total Value
$413.46K
Shares Held After
15,389
% of Holdings
28.7%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
3,562
Price
$37.33
Total Value
$132.97K
Shares Held After
35,622
% of Holdings
9.1%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
9,256
Price
$36.26
Total Value
$335.60K
Shares Held After
39,184
% of Holdings
19.1%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
19,032
Price
$35.24
Total Value
$670.73K
Shares Held After
48,440
% of Holdings
28.2%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
8,150
Price
$34.36
Total Value
$280.06K
Shares Held After
67,472
% of Holdings
10.8%
Showing 1251–1300 of 5133 transactions (page 26 of 103)